Bronstein, gewirtz & grossman, llc notifies shareholders of immunitybio inc. (ibrx) investigation

New york--(business wire)---- $ibrx #classaction--attorney advertising--bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of immunitybio inc. (“immunitybio” or “the company”) (nasdaq: ibrx). investors who purchased immunitybio securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ibrx. the investigation concerns whether immunitybio has violated federal securities laws. on may 11, 2023, reuters.
IBRX Ratings Summary
IBRX Quant Ranking